Study of the Effect of FLUTTER® VRP1 (PEP and Oscillating High Frequency). (FLUTTER®VRP1)
Bronchiectasis
About this trial
This is an interventional treatment trial for Bronchiectasis focused on measuring Bronchiectasis, Pulmonary function, Respiratory muscle strength, Respiratory secretions
Eligibility Criteria
Inclusion Criteria:
- Non Cystic Fibrosis Bronchiectasis
- Amount of secretion sufficient for analysis
- Capable of fulfilling the experimental protocol
Exclusion Criteria:
- Acute pulmonary disease
- Presence of any respiratory infection in the last four weeks
Sites / Locations
- Faculty of Medicine of Ribeirão Preto, University of Sao Paulo
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Active Comparator
Placebo Comparator
Sham Comparator
Flutter group
PEP group
control group
Group Sham
In Flutter group the exercise used the Flutter ®VRP1 (VarioRaw SA, Switzerland).
In PEP group the exercise used the Flutter ®VRP1 (VarioRaw SA, Switzerland) without the steel ball inside, with the closure of so many holes as necessary to produce a positive expiratory pressure equivalent to pressure achieved by patients during the performance with the ball in the Flutter®VRP1.
In placebo patients were assessed as pulmonary function, respiratory muscle strength and transport properties of respiratory secretions
Exercise with Flutter®VRP1 without the ball inside